We are live on ! Find out more
EMMA

Emmaus Life Sciences, Inc. Common Stock
EMMA

Delisted

EMMA was delisted on the 10th of September, 2019.

Back to rankings

6 hedge funds and large institutions have $258K invested in Emmaus Life Sciences, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
Millennium Management
New York
+$81.8K
2
CC
Cannell & Co
New York
+$77.5K
3
FFA
First Foundation Advisors
California
+$62K
4
PAM
Panagora Asset Management
Massachusetts
+$25.6K
5
HFM
Hartford Financial Management
Connecticut
+$17.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$80K +$81.8K +3,515 New
CC
2
Cannell & Co
New York
$76K +$77.5K +3,333 New
FFA
3
First Foundation Advisors
California
$61K +$62K +2,667 New
PAM
4
Panagora Asset Management
Massachusetts
$25K +$25.6K +1,100 New
HFM
5
Hartford Financial Management
Connecticut
$16K +$17.1K +733 New
Bank of America
6
Bank of America
North Carolina
– +$47 +2 New

EMMA Hedge Fund Activity: Q3 2017 in Review

6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q3 2017, worth a combined $258K.

Buyers outnumbered sellers: 6 funds opened new EMMA positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $81.8K.

  • 6 institutional investors held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q3 2017, up from 0 in Q2 2017.
  • Funds reported $258K of Emmaus Life Sciences, Inc. Common Stock stock for Q3 2017.
  • 6 funds opened new Emmaus Life Sciences, Inc. Common Stock positions in Q3 2017 and 0 closed out, a net change of +6 holders.
  • The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q3 2017 was Millennium Management, an estimated $81.8K added.

Based on aggregated 13F filings for Q3 2017.